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• Quasi-palindrome (QP) mutations are almost 
perfect inverted repeats of nucleotides capable of 
forming DNA secondary structures such as 
hairpins, which can block DNA replication and 
increase the chances of mutation (1)
• If DNA replication is blocked by secondary DNA 
structures, the DNA polymerase switches to the 
alternative DNA strands, and continues to use this 
as its template. This mutation is known as 
“Template-switching”, and it results in a perfect 
palindrome mutation from a quasi-palindromic 
sequence (1,2)
• There are many known side effects of anticancer 
drugs, including increased intensity of DNA 
mutation, since these drugs work in a non-specific 
manner that affects all body cells.
Introduction
Objective
• Using a chromosomal reporter in E. coli, specific 
for QP mutations, the rate of template switch 
mutations in the LacZ gene can determined (1,2)
• A template switch mutation in the QP reporter 
makes a non-functional LacZ gene functional, 
thus reporting only QP mutants (1,2)
• Template switching events are analyzed and 
confirmed by DNA sequencing.  
• In individual trials, the E.coli chromosomal 
reporter is treated with Taxol, Fulvestrant, 
Exemestane, Tamoxifen citrate, and Letrozole.
Materials & Methods 
• We expect the rate of QP mutations to be higher 
after treatment of all the chemotherapy drugs we 
selected.
• Tamoxifen citrate and Fulvestrant can affect the 
rates of QP mutation because their prolonged 
binding to the nuclear chromatin results in 
impaired DNA polymerase activity in 
eukaryotes. Therefore, it can have a similar 
effect in bacterial cells if it blocks DNA 
polymerase (3)
• Taxol binds to tubulin and inhibits the 
disassembly of microtubules, thereby resulting in 
the inhibition of cell division in eukaryotes. It is 
assumed that a similar process will happen in 
bacteria since cell division is controlled by the 
tubulin homolog FtsZ (3)
• Exemestane and Letrozole are a steroidal 
inhibitor of aromatase (a cytochrome P450). 
Inhibiting enzymes within this family of 
enzymes may effect the process of DNA 
replication in bacteria as well, thus increasing 
QP mutation rates (3)
Expected Results Future Directions
▪ We will test these drugs to confirm our 
predictions for their impact in QP mutation rates.
▪ We will also set up experiments using these 
drugs in conjunction with each other since 
patients undergoing chemotherapy typically 
receive more that one drug at a time. 
▪ We will do a screen for other drugs in the library 
for their ability to increase QP mutation rates.
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This study aims to evaluate the rate of Quasi-
palindrome mutations in E. coli after exposure of 
selected FDA-approved chemotherapeutic drugs.
This research has the potential to give us further 
understanding of the effect of anti-cancer drugs 
during DNA replication. 
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Figure 1: At imperfect hairpin sites, or Quasi 
palindromes, a mutation can occur creating a 
potentially more stable secondary structure; a perfect 
hairpin making into a perfect palindrome.
Figure 2: This reporter was created using a natural hairpin 
site in E. coli  found at the LacZ gene.  The chromosomal 
reporter will indicate an activated gene which can only 
happen through a template-switch mutation.
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Figure 4: Predicted comparative levels of mutations after 
treatment with selected drugs. We predict that Tamoxifen 
citrate and Fulvestrant will have the highest impact on QP 
mutations because of their direct effect on DNA polymerase. 
Exemestane and Letrozole are expected to have the lowest 
impact of QP rates because they target enzymes within the ER 
away from DNA replication. Taxol should give a mutation rate 
in between these values.
Figure 5: Predicted comparative levels of mutations after 
treatment with selected drugs in conjunction with others. We 
predict that Tamoxifen citrate and Letrozole would create a 
higher level of mutations compared to their individual 
treatment because these combinations are frequently used in 
the treatment of cancer patients. 
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